Clinical Trial Update: A Study to Investigate the Antiviral Effect, Safety, Tolerability and Pharmacokinetics of VH3739937 in in Treatment-Naive Adults Living With HIV-1 [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the antiviral effect, safety, tolerability and pharmacokinetics of VH3739937 in treatment-naive adults with HIV-1 has been terminated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• VH3739937

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV Infections | Phase 2 | Status: TERMINATED | Results posted: 2025-10-20